Table 3:
Mixed-effects model results for patients aged 75 years or more before and after implementation of the Quebec Alzheimer Plan*
| Variable | No. (%) of patients | OR (95% Cl) | ICC | |
|---|---|---|---|---|
| Before n = 944 |
After n = 975 |
|||
| Documentation of cognitive status | 351 (37.2) | 440 (45.1) | 1.46 (1.18–1.81) | 0.03 |
| Documented diagnosis of neurocognitive disorder | 208 (22.0) | 255 (26.2) | 1.25 (0.98–1.60) | 0.02 |
| Dementia | 127 (13.4) | 141 (14.5) | – | – |
| Mild cognitive impairment | 41 (4.3) | 52 (5.3) | – | – |
| Unspecified | 40 (4.2) | 62 (6.4) | – | - |
| No documented diagnosis of neurocognitive disorder | 736 (78.0) | 720 (73.8) | – | – |
| Cognitive testing† | 137 (14.6) n = 940 |
166 (17.1) n = 972 |
1.21 (0.92–1.60) | 0.03 |
| Referral to memory clinic‡ | 22 (2.5) n = 886 |
19 (2.1) n = 901 |
0.84 (0.42–1.68) | 0.04 |
| Justified referral§¶** | 14 (63.6) | 16 (84.2) | – | – |
| Uncertainty | 6 (42.9) | 7 (43.8) | – | – |
| Family request | 1 (7.1) | 5 (31.2) | ||
| Presence of depression | 1 (7.1) | 2 (12.5) | – | – |
| Complex medication management | 3 (21.4) | 0 (0.0) | ||
| Complex patient management | 6 (42.9) | 6 (37.5) | – | – |
| Other reason¶†† | 2 (9.1) | 0 (0.0) | ||
| Unjustified referral¶ | 6 (27.3) | 3 (15.8) | – | – |
| No prior evaluation | 3 (50.0) | 2 (66.7) | – | – |
| Blank referral | 3 (50.0) | 1 (33.3) | – | – |
Note: CI = confidence interval, ICC = intraclass correlation coefficient, OR = odds ratio.
*
Model estimates adjusted for age, sex and number of medications.
†
Excluding patients who refused the evaluation.
‡
Excluding patients referred before the study period.
¶
Proportions of subgroups.
**
There could be more than 1 reason for referral.
††
Documented reasons not mentioned in Canadian guidelines.